Berger EA - Search Results

1

Human immunodeficiency virus envelope glycoprotein/CD4-mediated fusion of nonprimate cells with human cells.

Ashorn PA, Berger EA, Moss B. Ashorn PA, et al. Among authors: berger ea. J Virol. 1990 May;64(5):2149-56. doi: 10.1128/JVI.64.5.2149-2156.1990. J Virol. 1990. PMID: 2109100 Free PMC article.

2

Therapeutic strategies employing CD4, the HIV receptor.

Ashorn P, Moss B, Berger EA. Ashorn P, et al. Among authors: berger ea. Adv Exp Med Biol. 1992;312:71-81. doi: 10.1007/978-1-4615-3462-4_6. Adv Exp Med Biol. 1992. PMID: 1514446 Review. No abstract available.

3

Human immunodeficiency virus type 1 envelope glycoprotein molecules containing membrane fusion-impairing mutations in the V3 region efficiently undergo soluble CD4-stimulated gp120 release.

Berger EA, Sisler JR, Earl PL. Berger EA, et al. J Virol. 1992 Oct;66(10):6208-12. doi: 10.1128/JVI.66.10.6208-6212.1992. J Virol. 1992. PMID: 1527858 Free PMC article.

4

Elimination of infectious human immunodeficiency virus from human T-cell cultures by synergistic action of CD4-Pseudomonas exotoxin and reverse transcriptase inhibitors.

Ashorn P, Moss B, Weinstein JN, Chaudhary VK, FitzGerald DJ, Pastan I, Berger EA. Ashorn P, et al. Among authors: berger ea. Proc Natl Acad Sci U S A. 1990 Nov;87(22):8889-93. doi: 10.1073/pnas.87.22.8889. Proc Natl Acad Sci U S A. 1990. PMID: 1701055 Free PMC article.

5

Activity of CD4-Pseudomonas exotoxin against cells expressing diverse forms of the HIV and SIV envelope glycoproteins.

Ashorn P, Moss B, Berger EA. Ashorn P, et al. Among authors: berger ea. J Acquir Immune Defic Syndr (1988). 1992;5(1):70-7. J Acquir Immune Defic Syndr (1988). 1992. PMID: 1738090

6

Stimulation of glycoprotein gp120 dissociation from the envelope glycoprotein complex of human immunodeficiency virus type 1 by soluble CD4 and CD4 peptide derivatives: implications for the role of the complementarity-determining region 3-like region in membrane fusion.

Berger EA, Lifson JD, Eiden LE. Berger EA, et al. Proc Natl Acad Sci U S A. 1991 Sep 15;88(18):8082-6. doi: 10.1073/pnas.88.18.8082. Proc Natl Acad Sci U S A. 1991. PMID: 1896455 Free PMC article.

7

Anti-HIV activity of CD4-Pseudomonas exotoxin on infected primary human lymphocytes and monocyte/macrophages.

Ashorn P, Englund G, Martin MA, Moss B, Berger EA. Ashorn P, et al. Among authors: berger ea. J Infect Dis. 1991 Apr;163(4):703-9. doi: 10.1093/infdis/163.4.703. J Infect Dis. 1991. PMID: 2010626

8

Anti-HIV effects of CD4-Pseudomonas exotoxin on human lymphocyte and monocyte/macrophage cell lines.

Ashorn P, Moss B, Berger EA. Ashorn P, et al. Among authors: berger ea. Ann N Y Acad Sci. 1990;616:149-54. doi: 10.1111/j.1749-6632.1990.tb17835.x. Ann N Y Acad Sci. 1990. PMID: 2078015

9

Recombinant CD4-Pseudomonas exotoxin hybrid protein displays HIV-specific cytotoxicity without affecting MHC class II-dependent functions.

Berger EA, Chaudhary VK, Clouse KA, Jaraquemada D, Nicholas JA, Rubino KL, Fitzgerald DJ, Pastan I, Moss B. Berger EA, et al. AIDS Res Hum Retroviruses. 1990 Jun;6(6):795-804. doi: 10.1089/aid.1990.6.795. AIDS Res Hum Retroviruses. 1990. PMID: 2114147

10

A soluble recombinant polypeptide comprising the amino-terminal half of the extracellular region of the CD4 molecule contains an active binding site for human immunodeficiency virus.

Berger EA, Fuerst TR, Moss B. Berger EA, et al. Proc Natl Acad Sci U S A. 1988 Apr;85(7):2357-61. doi: 10.1073/pnas.85.7.2357. Proc Natl Acad Sci U S A. 1988. PMID: 2451247 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

144 results

Search Page